Medicine and Dentistry
Cystic Fibrosis
100%
Lung
58%
Patient
53%
Patient with Cystic Fibrosis
39%
Therapeutic Procedure
34%
Syndrome
28%
Family
23%
Child
19%
Pseudomonas aeruginosa
17%
Silo-Filler's Disease
16%
Airway Obstruction
16%
Forced Expiratory Volume
15%
Scoring System
13%
Symptom
12%
Deterioration
12%
Age
11%
Heart Left Ventricle Filling
11%
Pulmonary Valve
11%
Obstructive Sleep Apnea
11%
Ciprofloxacin
11%
Tobramycin
11%
Emphysema
11%
Pediatrics
11%
Stent
11%
Tetralogy of Fallot
11%
Ceftazidime
11%
Experience
11%
Cystic Adenomatoid Malformation
11%
Pharmacist
11%
Pneumoparotid
11%
Pulmonary Heart Disease
11%
Depression
11%
Chest Wall Oscillation
11%
Continuous Positive Airway Pressure
11%
Denufosol
11%
Doppler Echocardiography
11%
Infant
9%
Lung Function
9%
Health
8%
Self Esteem
8%
Placebo
8%
Follow up
7%
Breathing
7%
Absence
7%
Measurement
6%
Combination Therapy
5%
Body Position
5%
Systolic Dysfunction
5%
Heart Atrium Contraction
5%
Relaxation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
80%
Pseudomonas aeruginosa
28%
Ceftazidime
23%
Placebo
13%
Exocrine Pancreatic Insufficiency
11%
Cefepime
11%
Denufosol
11%
Ciprofloxacin
11%
Tobramycin
11%
Pancrelipase
11%
Malabsorption
11%
Adverse Event
8%
Nitrogen
6%
Fat
6%
Antibiotics
5%
Aminoglycoside
5%
Biochemistry, Genetics and Molecular Biology
Cystic Fibrosis
34%
Gene
16%
Association
13%
Exome Sequencing
11%
BRCA2
11%
Ceftazidime
11%
Cholesterol
11%
Candidate Gene
11%
Coding
11%
Pressure
11%
Pseudomonas aeruginosa
11%
Cefepime
11%
Oscillation
11%
Breathing
11%
Low-Density Lipoprotein
9%
BRIP1
7%
Genotyping
5%
